Efficacy of Alternating Immunochemotherapy Consisting of R-CHOP + R-HAD vs R-CHOP Alone, Followed by Maintenance Therapy Consisting of Additional Lenalidomide + Rituximab vs Rituximab Alone for Older Patients With Mantle Cell Lymphoma
Latest Information Update: 03 Jun 2024
At a glance
- Drugs Lenalidomide (Primary) ; Rituximab (Primary) ; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Prednisone; Vincristine
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- Acronyms MCL-R2Elderly
- 14 Dec 2021 Results presented at the 63rd American Society of Hematology Annual Meeting and Exposition
- 14 Dec 2021 Results presented at the 63rd American Society of Hematology Annual Meeting and Exposition
- 01 Nov 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.